Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 69
  2. 70
  3. 71
  4. 72
  5. 73
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Casirivimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5200-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Casirivimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5200-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Casirivimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5200-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Casirivimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5200-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Casirivimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5200-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Sotrovimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5201-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Sotrovimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5201-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Sotrovimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5201-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Sotrovimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5201-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Sotrovimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5201-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Sotrovimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5201-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Ifinatamab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5204-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Ifinatamab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5204-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Ifinatamab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5204-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Ifinatamab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5204-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Ifinatamab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5204-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Ifinatamab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5204-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Elotuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5202-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Elotuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5202-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Elotuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5202-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Elotuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5202-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Elotuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5202-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Elotuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5202-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Bavunalimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5203-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Bavunalimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5203-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Name Preis
Casirivimab Biosimilar -­ Research Grade Anmelden Casirivimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Casirivimab Biosimilar -­ Research Grade Anmelden Casirivimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Casirivimab Biosimilar -­ Research Grade Anmelden Casirivimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Casirivimab Biosimilar -­ Research Grade Anmelden Casirivimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Casirivimab Biosimilar -­ Research Grade Anmelden Casirivimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 100 mg
Lieferbar
Sotrovimab Biosimilar -­ Research Grade Anmelden Sotrovimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Sotrovimab Biosimilar -­ Research Grade Anmelden Sotrovimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Sotrovimab Biosimilar -­ Research Grade Anmelden Sotrovimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Sotrovimab Biosimilar -­ Research Grade Anmelden Sotrovimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Sotrovimab Biosimilar -­ Research Grade Anmelden Sotrovimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Sotrovimab Biosimilar -­ Research Grade Anmelden Sotrovimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 100 mg
Lieferbar
Ifinatamab Biosimilar -­ Research Grade Anmelden Ifinatamab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Ifinatamab Biosimilar -­ Research Grade Anmelden Ifinatamab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Ifinatamab Biosimilar -­ Research Grade Anmelden Ifinatamab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Ifinatamab Biosimilar -­ Research Grade Anmelden Ifinatamab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Ifinatamab Biosimilar -­ Research Grade Anmelden Ifinatamab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Ifinatamab Biosimilar -­ Research Grade Anmelden Ifinatamab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 100 mg
Lieferbar
Elotuzumab Biosimilar -­ Research Grade Anmelden Elotuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Elotuzumab Biosimilar -­ Research Grade Anmelden Elotuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Elotuzumab Biosimilar -­ Research Grade Anmelden Elotuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Elotuzumab Biosimilar -­ Research Grade Anmelden Elotuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Elotuzumab Biosimilar -­ Research Grade Anmelden Elotuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Elotuzumab Biosimilar -­ Research Grade Anmelden Elotuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 100 mg
Lieferbar
Bavunalimab Biosimilar -­ Research Grade Anmelden Bavunalimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Bavunalimab Biosimilar -­ Research Grade Anmelden Bavunalimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 69
  2. 70
  3. 71
  4. 72
  5. 73
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top